Clinical Trials Directory

Trials / Unknown

UnknownNCT02529969

Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes

Curcumin Supplementation and Type 2 Diabetes

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
National Nutrition and Food Technology Institute · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Various kinds of antidiabetic drugs have been developed, but most of them have side effects. Recently, the use of natural plant products has gained more attention among scientists in order to prevent diabetic vascular complications. Curcumin is a natural yellow product derived from the turmeric rhizome which has shown to be non-toxic and exhibits various bio¬logical activities such as anti-oxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. Curcumin is effective in reducing glycemic index and hyperlipidemia in rodent models and is relatively inexpensive and safe. Most of the studies conducted on animal model, and just a few of them are on human model. The present study was planned to evaluate the effects of curcumin supplementation on serum levels of lipid profile and inflammatory markers in patients with type 2 diabetes

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcurcumin
DIETARY_SUPPLEMENTPlacebo

Timeline

Start date
2015-07-01
Primary completion
2016-01-01
First posted
2015-08-20
Last updated
2015-08-20

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02529969. Inclusion in this directory is not an endorsement.